Overview Financials News + Filings Key Docs Charts Transactions Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Director departure
|
|
Biohaven Pharmaceutical Holding Co Ltd. (BHVN)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/03/2022 |
4
| CHILDS JOHN W (Director) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.|
Txns:
| Disposed/sold 3,025,001 shares
@ $148.5, valued at
$449.2M
Disposed/sold 10,000 shares
@ $148.5, valued at
$1.5M
Disposed/sold 8,239 options to buy
@ $0
Disposed/sold 11,996 options to buy
@ $0 |
|
| 10/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/03/2022 |
4
| Heffernan Michael Thomas (Director) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.|
Txns:
| Disposed/sold 3,320 options to buy
@ $0
Disposed/sold 8,239 options to buy
@ $0
Disposed/sold 11,996 options to buy
@ $0
Disposed/sold 26,200 options to buy
@ $0 |
|
| 10/03/2022 |
4
| GREGORY JULIA P (Director) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.|
Txns:
| Disposed/sold 8,239 options to buy
@ $0
Disposed/sold 11,996 options to buy
@ $0
Disposed/sold 18,000 options to buy
@ $0 |
|
| 10/03/2022 |
4
| JONES WILLIAM A JR (CCO-Migraine & Common Disease) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.|
Txns:
| Disposed/sold 14,226 shares
@ $148.5, valued at
$2.1M
Disposed/sold 11,250 options to buy
@ $0
Disposed/sold 10,000 options to buy
@ $0
Disposed/sold 3,000 options to buy
@ $0
Disposed/sold 775 options to buy
@ $0
Disposed/sold 29,225 options to buy
@ $0
Disposed/sold 2,398 options to buy
@ $0
Disposed/sold 37,602 options to buy
@ $0
Disposed/sold 1,742 options to buy
@ $0
Disposed/sold 28,258 options to buy
@ $0
Disposed/sold 5,913 options to buy
@ $0 |
|
| 10/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/03/2022 |
4
| HUGIN ROBERT J (Director) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.|
Txns:
| Disposed/sold 2,900 shares
@ $148.5, valued at
$430.7k
Disposed/sold 3,417 options to buy
@ $0
Disposed/sold 8,239 options to buy
@ $0
Disposed/sold 11,996 options to buy
@ $0
Disposed/sold 18,948 options to buy
@ $0 |
|
| 10/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/03/2022 |
4
| Bailey Gregory (Director) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.|
Txns:
| Disposed/sold 2,583,658 shares
@ $148.5, valued at
$383.7M
Disposed/sold 8,239 options to buy
@ $0
Disposed/sold 11,996 options to buy
@ $0
Disposed/sold 18,000 options to buy
@ $0 |
|
| 10/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/22/2022 |
4
| Bailey Gregory (Director) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.|
Txns:
| Bought 38,000 shares
@ $148.0441, valued at
$5.6M
|
|
| 05/12/2022 |
4
| Clark George C. (VP, Chief Accounting Officer) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.|
Txns:
| Sold 4,200 shares
@ $141.5, valued at
$594.3k
Exercised 2,250 options to buy
@ $53.76, valued at
$121k
|
|
| 05/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/29/2022 |
4
| GREGORY JULIA P (Director) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.|
Txns:
| Granted 8,239 options to buy
@ $97.74, valued at
$805.3k
|
|
| 04/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/24/2022 |
4
| Clark George C. (VP, Chief Accounting Officer) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.|
Txns:
| Sold 3,196 shares
@ $114.9293, valued at
$367.3k
Sold 2,159 shares
@ $116.0189, valued at
$250.5k
Sold 500 shares
@ $118.048, valued at
$59k
Sold 3,520 shares
@ $119.3694, valued at
$420.2k
Exercised 3,750 options to buy
@ $53.76, valued at
$201.6k
Exercised 1,920 options to buy
@ $32.42, valued at
$62.2k
|
|
| 01/12/2022 |
4
| Clark George C. (VP, Chief Accounting Officer) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.|
Txns:
| Paid exercise price by delivering 464 shares
@ $128.87, valued at
$59.8k
Exercised 1,000 options to buy
@ $0 |
|
| 01/12/2022 |
4
| Stock Elyse (Chief Medical Officer) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.|
Txns:
| Exercised 937 options to buy
@ $0 |
|
| 01/12/2022 |
4
| Mehta Kishan (Director) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.|
Txns:
| Exercised 1,875 options to buy
@ $0 |
|
| 01/07/2022 |
4
| Buten Matthew (CFO) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.|
Txns:
| Granted 26,000 options to buy
@ $128.87, valued at
$3.4M
|
|
| 01/07/2022 |
4
| Tilton John (Chief Commercial Officer) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.|
Txns:
| Paid exercise price by delivering 551 shares
@ $123.86, valued at
$68.2k
Paid exercise price by delivering 342 shares
@ $128.87, valued at
$44.1k
Exercised 1,250 options to buy
@ $0
Granted 7,000 options to buy
@ $128.87, valued at
$902.1k
Granted 3,500 options to buy
@ $0
Exercised 875 options to buy
@ $0 |
|
| 01/07/2022 |
4
| Clark George C. (VP, Chief Accounting Officer) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.|
Txns:
| Paid exercise price by delivering 409 shares
@ $123.86, valued at
$50.7k
Paid exercise price by delivering 522 shares
@ $128.87, valued at
$67.3k
Exercised 875 options to buy
@ $0
Granted 10,000 options to buy
@ $128.87, valued at
$1.3M
Granted 5,000 options to buy
@ $0
Exercised 1,000 options to buy
@ $0 |
|
| 01/07/2022 |
4
| Conway Charles (Chief Scientific Officer) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.|
Txns:
| Paid exercise price by delivering 1,800 shares
@ $123.86, valued at
$222.9k
Exercised 3,750 options to buy
@ $0
Granted 23,000 options to buy
@ $128.87, valued at
$3M
Granted 11,500 options to buy
@ $0 |
|
|
|
|